中国P站

Gut-Brain Axis; Gut Microbiome; Enteric Nervous System; Central Nervous System; Probiotics; Prebiotics; Fecal Microbiota Transplantation; Short-Chain Fatty Acids; Inflammation; Neurodegenerative Diseases

Introduction

The gut-brain axis (GBA) involves bidirectional communication between the gut microbiome, the enteric nervous system, and the central nervous system[1].

This complex interaction influences both gastrointestinal and neurological functions, with implications for mental health, neurodevelopmental disorders, and neurodegenerative diseases[1].

Diet significantly affects the gut microbiome's composition and function, thereby influencing brain health[2].

Specific nutrients and dietary patterns can modulate the production of neurotransmitters and other signaling molecules in the gut, impacting mood, cognition, and behavior[2].

Probiotics and prebiotics have shown promise in modulating the gut microbiome and improving mental health outcomes[3].

Certain probiotic strains can reduce anxiety and depression symptoms, while prebiotics can promote the growth of beneficial bacteria in the gut[3].

Fecal microbiota transplantation (FMT) involves transferring fecal material from a healthy donor to a recipient to restore gut microbial diversity[4].

FMT has shown efficacy in treating recurrent Clostridioides difficile infection and is being explored as a potential therapy for other conditions, including inflammatory bowel disease, metabolic disorders, and neurological diseases[4].

Short-chain fatty acids (SCFAs), such as butyrate, acetate, and propionate, are produced by the gut microbiome through the fermentation of dietary fibers[5].

SCFAs have various beneficial effects on gut health, including promoting intestinal barrier integrity, reducing inflammation, and modulating immune responses[5].

They also influence brain function through direct and indirect mechanisms, affecting neurotransmitter synthesis and neuroinflammation[5].

The enteric nervous system (ENS), often referred to as the 'second brain,' is a complex network of neurons in the gut wall that regulates gastrointestinal functions[6].

The ENS communicates with the central nervous system (CNS) via the vagus nerve and other pathways, influencing appetite, satiety, and stress responses[6].

Disruptions in ENS function can contribute to gastrointestinal disorders and neurological conditions[6].

The vagus nerve plays a crucial role in the gut-brain axis, transmitting sensory information from the gut to the brain and carrying efferent signals from the brain to the gut[7].

Vagal nerve stimulation has shown promise in treating various conditions, including epilepsy, depression, and inflammatory bowel disease[7].

Modulation of vagal nerve activity through dietary or pharmacological interventions may offer therapeutic benefits for gut-brain disorders[7].

Inflammation in the gut can affect brain function by disrupting the blood-brain barrier, activating microglia, and altering neurotransmitter systems[8].

Chronic inflammation in the gut is associated with increased risk of neurological disorders, including Alzheimers disease, Parkinsons disease, and multiple sclerosis[8].

Targeting gut inflammation through dietary and therapeutic interventions may help prevent or manage these conditions[8].

The gut microbiome can influence the development and progression of neurodegenerative diseases, such as Alzheimers and Parkinsons disease, through various mechanisms, including the production of amyloid proteins, the modulation of neuroinflammation, and the alteration of neurotransmitter metabolism[9].

Strategies aimed at maintaining a healthy gut microbiome may help prevent or delay the onset of these diseases[9].

The gut-brain axis plays a critical role in mental health, with disruptions in gut microbiome composition and function being linked to anxiety, depression, and other mood disorders[10].

Interventions that target the gut microbiome, such as dietary changes, probiotics, and FMT, may offer novel therapeutic approaches for improving mental health outcomes[10].

Description

The gut-brain axis represents a complex bidirectional communication network between the gut microbiome, the enteric nervous system, and the central nervous system[1]. This intricate interplay impacts both gastrointestinal and neurological functions, revealing implications for mental health, neurodevelopmental disorders, and neurodegenerative diseases[1]. Emerging therapeutic strategies targeting the GBA include dietary interventions, probiotics, and fecal microbiota transplantation, highlighting the potential for innovative treatment approaches[1].

Diet plays a significant role in shaping the gut microbiome's composition and function, ultimately influencing brain health[2]. Specific nutrients and dietary patterns can modulate the production of neurotransmitters and signaling molecules within the gut, subsequently affecting mood, cognition, and behavior[2]. High-fiber diets promote beneficial microbial diversity and the production of short-chain fatty acids, while processed foods and high-sugar diets can disrupt the gut microbiome and promote inflammation[2].

Probiotics and prebiotics have demonstrated promising potential in modulating the gut microbiome and improving mental health outcomes[3]. Specific probiotic strains can alleviate symptoms of anxiety and depression, while prebiotics encourage the growth of beneficial bacteria within the gut[3]. Clinical trials are currently underway to further investigate the efficacy of these interventions for various neurological and psychiatric conditions[3]. Fecal microbiota transplantation (FMT) involves the transfer of fecal material from a healthy donor to a recipient to restore gut microbial diversity[4].

FMT has proven effective in treating recurrent Clostridioides difficile infection and is being explored as a potential therapy for other conditions, including inflammatory bowel disease, metabolic disorders, and neurological diseases[4]. Short-chain fatty acids (SCFAs), such as butyrate, acetate, and propionate, are produced by the gut microbiome through dietary fiber fermentation[5]. SCFAs exert various beneficial effects on gut health, including promoting intestinal barrier integrity, reducing inflammation, and modulating immune responses[5]. Furthermore, they influence brain function through direct and indirect mechanisms, impacting neurotransmitter synthesis and neuroinflammation[5]. The enteric nervous system (ENS), often referred to as the 'second brain', is a complex network of neurons within the gut wall that regulates gastrointestinal functions[6]. The ENS communicates with the central nervous system (CNS) via the vagus nerve and other pathways, influencing appetite, satiety, and stress responses[6]. Disruptions in ENS function can contribute to gastrointestinal disorders and neurological conditions[6].

Conclusion

The gut-brain axis (GBA) involves bidirectional communication between the gut microbiome, the enteric nervous system, and the central nervous system, influencing gastrointestinal and neurological functions with implications for mental health and neurodegenerative diseases. Dietary interventions, probiotics, and fecal microbiota transplantation are therapeutic strategies. Diet significantly affects the gut microbiome's composition and function, thereby influencing brain health. Specific nutrients and dietary patterns modulate neurotransmitter production, impacting mood and cognition. High-fiber diets promote beneficial microbial diversity and short-chain fatty acid production, while processed foods disrupt the gut microbiome and promote inflammation. Probiotics and prebiotics modulate the gut microbiome, improving mental health. Certain probiotic strains reduce anxiety and depression, while prebiotics promote beneficial bacteria growth. Clinical trials investigate their efficacy for neurological and psychiatric conditions. Fecal microbiota transplantation (FMT) restores gut microbial diversity. FMT treats Clostridioides difficile infection and is explored for inflammatory bowel disease, metabolic disorders, and neurological diseases. More research is needed to optimize FMT protocols and ensure long-term safety and efficacy. Short-chain fatty acids (SCFAs) are produced by the gut microbiome through dietary fiber fermentation. SCFAs have beneficial effects on gut health, including promoting intestinal barrier integrity, reducing inflammation, and modulating immune responses. They also influence brain function through direct and indirect mechanisms, affecting neurotransmitter synthesis and neuroinflammation. The enteric nervous system (ENS) regulates gastrointestinal functions and communicates with the central nervous system (CNS) via the vagus nerve and other pathways, influencing appetite, satiety, and stress responses. Disruptions in ENS function can contribute to gastrointestinal disorders and neurological conditions. The vagus nerve transmits sensory information from the gut to the brain and carries efferent signals from the brain to the gut. Vagal nerve stimulation treats epilepsy, depression, and inflammatory bowel disease. Modulation of vagal nerve activity through dietary or pharmacological interventions may offer therapeutic benefits for gut-brain disorders. Inflammation in the gut can affect brain function by disrupting the blood-brain barrier, activating microglia, and altering neurotransmitter systems. Chronic inflammation in the gut is associated with increased risk of neurological disorders, including Alzheimers disease, Parkinsons disease, and multiple sclerosis. Targeting gut inflammation through dietary and therapeutic interventions may help prevent or manage these conditions. The gut microbiome can influence the development and progression of neurodegenerative diseases, such as Alzheimers and Parkinsons disease, through various mechanisms, including the production of amyloid proteins, the modulation of neuroinflammation, and the alteration of neurotransmitter metabolism. Strategies aimed at maintaining a healthy gut microbiome may help prevent or delay the onset of these diseases. The gut-brain axis plays a critical role in mental health, with disruptions in gut microbiome composition and function being linked to anxiety, depression, and other mood disorders. Interventions that target the gut microbiome, such as dietary changes, probiotics, and FMT, may offer novel therapeutic approaches for improving mental health outcomes.

References

1. John FC, Kirsten JO, Kanika S (2020) .Gastroenterology 158:1069-1085.

   , ,

2. Philip S, Kyung HK, Darya T (2019) .Nat Microbiol 4:396-403.

   , ,

3. Maria IP, Premysl B, Alexander CF (2017) .Am J Gastroenterol 112:921-931.

   , ,

4. James RA, Michael JH, Colleen RK (2019) .Gastroenterology 157:306-324.

   , ,

5. Bahareh D, Lukas VO, Bert V (2019) .Nat Rev Gastroenterol Hepatol 16:461-478.

   , ,

6. Michael R, Michael DG (2016) .Nat Rev Gastroenterol Hepatol 13:517-28.

   , ,

7. Bruno B, Virginie S, Sandrine P (2016) .Front Immunol 7:598.

   , ,

8. Ralf R, Piotr JW, Orhan A (2017) .Gut 66:1950-1966.

   , ,

9. Timothy RS, Jan WD, Teeraporn T (2016) .Cell 167:1469-1480.

   , Google Scholar,

10. Tai-Tong H, Jian-Bo L, Yu-Lin D (2019) .Brain Behav Immun 79:233-242.

    , ,